This site contains information about prescription peptide therapy protocols intended for adults. You must be 18 years of age or older to enter.
By entering, you confirm you are at least 18 years old and agree to our Terms of Service. All protocols require a valid physician prescription.
Pre-blended in a single lyophilized vial — one reconstitution, one draw, one injection. GLOW combines three of the most researched repair peptides into the most comprehensive tissue regeneration protocol available.
GLOW is not a convenience product — it's a mechanistic decision. Each of the three components targets a distinct healing pathway. Together, they cover collagen and extracellular matrix rebuilding, receptor-mediated tissue signaling, and cell migration with angiogenesis — the full spectrum of tissue repair biology.
GHK-Cu drives fibroblast activation and collagen synthesis. BPC-157 stimulates tendon fibroblast proliferation. TB-500 promotes the formation of new connective tissue. All three work on the extracellular matrix through complementary mechanisms.
The most complete research-backed tendon healing protocol available. BPC-157 + TB-500 is the established recovery stack; GHK-Cu adds the collagen synthesis and gene expression reset that makes repairs more structurally complete.
BPC-157 activates VEGFR2 to recruit blood vessel growth at injury sites; TB-500 drives systemic angiogenesis through actin/cell migration pathways. Combined, they create a richer vascular environment for healing tissue.
GHK-Cu's documented effects on collagen, elastin, and gene expression reset make GLOW effective for skin quality alongside musculoskeletal repair — a dual benefit not available in peptides focused solely on injury.
GHK-Cu influences ~31% of human genes. In the context of GLOW, this means the healing environment at injury and skin sites is actively reprogrammed toward a more youthful, regenerative state.
No three separate reconstitutions. No calculating three separate doses. One vial, one draw, one injection — pre-blended at the ratios most commonly used in research community protocols.
Reconstitute with bacteriostatic water. The GHK-Cu is dosed at 50mg per vial, so dosing is based on fraction of the vial content.
| Parameter | Detail |
|---|---|
| Reconstitution | Add 2–5 mL bacteriostatic water gently to lyophilized powder |
| Frequency | Once daily or every other day |
| Route | Subcutaneous — abdomen, upper thigh |
| Cycle Length | 4 – 12 weeks depending on protocol goals |
| Storage (reconstituted) | Refrigerate; use within 30 days |
The value of GLOW is not just convenience — it's precision. The 5:1 ratio of GHK-Cu to BPC-157/TB-500 reflects the typical research community practice of using more GHK-Cu per cycle (larger molecules, higher dose needed for collagen effects) alongside the smaller BPC-157 and TB-500 doses that produce tissue signaling effects. A pre-blended vial ensures consistent ratios in every injection without manual mixing.
KLOW adds KPV (a tripeptide with potent anti-inflammatory and gut-healing properties) to the GLOW formula. If your primary research focus is gut inflammation, IBD models, or combined gut+tissue healing, KLOW is the more targeted choice. GLOW is the core recovery and regeneration stack.
GLOW is a pre-blended peptide combination sold for research purposes only. None of the components (GHK-Cu, BPC-157, TB-500) are FDA-approved drugs. The information on this page is educational and does not constitute medical advice. Consult a qualified healthcare professional before any peptide protocol.
Pre-blended. Triple-analyte COA. Finnrick Analytics verified. Ships within 24 hours.
Get Started TodayMedical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. All protocols require evaluation and prescription by a licensed physician. You should consult a qualified healthcare provider before starting any new medical protocol. Individual results vary. Cinch Bio is not a pharmacy and does not dispense medications — all prescriptions are issued by independent licensed physicians and filled by licensed 503A compounding pharmacies.